Prescribing guidance

These guidelines aim to provide a simple effective, economical and empirical approach to the treatment of common infections; to minimise the emergence of bacterial resistance in the community.

This guideline is aimed at all community and non-specialist medical, nursing and pharmacy staff involved in the prescribing and management of recurrent urinary tract infections (UTIs). This guideline is intended for non-pregnant, non-catheterised women aged 16 years and over.

This guidance provides an evidence-based, accessible, antimicrobial prescribing strategy for managing Clostridioides difficile infection (CDI) in adults.

This guidance focuses on treatment of patients with non-valvular atrial fibrillation (NVAF) and incorporates a risk/benefit assessment tool, and a one-page summary for Welsh healthcare practitioners choosing a direct oral anticoagulant in this patient population.

This guideline aims to reduce variation in inhaler prescribing in the management of chronic obstructive pulmonary disease (COPD) and encourage consideration of the decarbonisation agenda of NHS Wales.

This guideline aims to reduce variation in inhaler prescribing in the management of adult asthma and encourage consideration of the decarbonisation agenda of NHS Wales.

This document provides guidance for healthcare professionals regarding prescribing duration, foodstuffs, complementary medicines and alternative therapies, common ailments, fertility treatment, erectile dysfunction, prescribing for self and family, visitors from overseas, travel and occupational health vaccines, prescribing situations not covered by the NHS including private care and private prescriptions, unlicensed medicines and prescribing outside national guidance.

These educational resources aim to support the prescribing of tramadol in NHS Wales within the complex context of pain management.

This guidance has been developed to help support healthcare professionals in the prescribing of SGLT-2 inhibitors in patients with type 2 diabetes mellitus and cardiovascular disease.

This educational pack aims to support the appropriate prescribing of hypnotics and anxiolytics across Wales by providing key health professionals with a practical approach for the initiation and review of hypnotic and anxiolytic prescribing.

The Welsh National Standards for Medication Review have been developed to provide a structured approach to medication review and are benchmarks for quality, with the aim of optimising patient safety and prescribing practice.

This document aims to inform and guide healthcare staff in NHS Wales about how to start nicotine replacement therapy (NRT) to manage nicotine withdrawal in adults who smoke and are admitted to hospital (secondary care).

This document updates the principles of best practice for shared care prescribing agreements.

This short ‘Best Practice Reminder’ document has been developed to inform primary care prescribers about avoiding the prescribing of nitrofurantoin in patients with suspected pyelonephritis, the rationale behind this and what can be prescribed in its place.

The aim of the counselling checklist is to assist healthcare professionals, working in community pharmacies, primary care and secondary care, in the essential counselling of patients on the safe and effective use of opioid patches.

This resource pack provides healthcare professionals with signposting and access to appropriate, relevant and up-to-date information on the non-pharmacological and pharmacological management of persistent (chronic) non-malignant pain in non-specialist settings.

This guidance is intended to provide managers, responsible individuals, registered nurses and care support workers in Welsh organisations with information on how and when a registered nurse may delegate the task of medicines support to a care support worker, and the necessary education and training standards, and policies and procedures that are required to facilitate this.

This document is intended for non-specialist practitioners engaged in the prescribing and monitoring of medical therapies used in the management of gender dysphoria.